RxDoctor Payments Data

Peter Pryzbylkowski, MD

Pain Medicine · Philadelphia, PANPI 1174751929

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $318,865 of the $506,247 with a category attached, or 63.0%. 37 manufacturers reported payments, led by Vertos Medical, Inc. at 47.3% of the total. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$506,247in general payments, 2019–2025

Across 798 payments — averaging $634.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertos Medical, Inc.$239K
  • Nevro Corp.$170K
  • Stryker$48K
  • Globus Medical$18K
  • Vertex$7K
  • Boston Scientific$7K
  • plus $18K from 31 others
$7,025in research payments, 2019–2025

Across 6 payments — averaging $1170.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertos Medical, Inc.$5K
  • Nevro Corp.$2K
  • Medtronic$1K

What the payments were for

  • Consulting fees$318,86563%
  • Speaking & faculty fees$104,99221%
  • Travel & lodging$51,34310%
  • Food & beverage$31,0476%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$506,247 in reported general payments places this provider in the 95th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$325,968
Medicare patients
566
Services billed
10,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib129$2,615
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen78$1,327
Lidocaine14$1,325
Gabapentin101$690
Oxycodone Hcl22$436
Cyclobenzaprine Hcl42$429
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$334
Pregabalin27$321
Methylprednisolone44$275
Ibuprofen50$168
Cephalexin32$145
Tizanidine Hcl30$143
Acetaminophen-CodeineAcetaminophen With Codeine14$112
Trazodone Hcl19$92
Tramadol Hcl42$82

Paid to pharmacies, not to this prescriber.

Other pain medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →